Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome

Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo

Clin Mol Hepatol. 2021;27(3):463-473. Published online February 15, 2021

DOI: https://doi.org/10.3350/cmh.2020.0351

View: 5624 Download: 167 Web of Science: 2 Crossref: 2

Editorial

Is liver biopsy still useful in the era of non-invasive tests?

Tae Seop Lim, Ja Kyung Kim

Clin Mol Hepatol. 2020;26(3):302-304. Published online July 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0081

View: 4405 Download: 134 Web of Science: 10 Crossref: 11

Original Article

Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017

Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim

Clin Mol Hepatol. 2020;26(2):209-215. Published online November 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.0065

View: 34199 Download: 407 Web of Science: 77 Crossref: 82

Editorial

A leap for the journal: Clinical and Molecular Hepatology enters a new era

Yoon Jun Kim

Clin Mol Hepatol. 2019;25(4):333-334. Published online December 17, 2019

DOI: https://doi.org/10.3350/cmh.2019.1004

View: 4243 Download: 57

Letter to the Editor

Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation

Karina Lucio de Medeiros Bastos, Caio Robledo Quaio, Fabiana Roberto Lima, Iana Manuelle Araújo, Candice Alves Tavares Araújo, Flávia Balbo Piazzon, Ismael Dale Cotrim Guerreiro da Silva, Gabriel Nuncio Benevides, Ana Cristina Tannuri, Uenis Tannuri, Ramiro Anthero Azevedo, Chong Ae Kim

Clin Mol Hepatol. 2019;25(1):86-91. Published online August 28, 2018

DOI: https://doi.org/10.3350/cmh.2018.0005

View: 8322 Download: 147 Web of Science: 2 Crossref: 1

Special Article

Journal metrics of Clinical and Molecular Hepatology based on the Web of Science Core Collection

Sun Huh

Clin Mol Hepatol. 2018;24(2):137-143. Published online June 22, 2018

DOI: https://doi.org/10.3350/cmh.2018.0018

View: 7334 Download: 81 Web of Science: 6 Crossref: 5

Erratum

Erratum

Clin Mol Hepatol. 2015;21(1):104-104. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.104
Corrects: Clin Mol Hepatol 2014;20(4):355

View: 5906 Download: 68

Review

The cost of liver disease in Korea: methodology, data, and evidence

Wankyo Chung

Clin Mol Hepatol. 2015;21(1):14-21. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.14

View: 8035 Download: 107 Web of Science: 17 Crossref: 18

Cost-of-illness studies: concepts, scopes, and methods

Changik Jo

Clin Mol Hepatol. 2014;20(4):327-337. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.327

View: 26435 Download: 687 Web of Science: 393 Crossref: 391

Overview and recent trends of systematic reviews and meta-analyses in hepatology

Gaeun Kim, Soon Koo Baik

Clin Mol Hepatol. 2014;20(2):137-150. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.137

View: 10240 Download: 104 Web of Science: 8 Crossref: 12

Original Article

Type and cause of liver disease in Korea: single-center experience, 2005-2010

Sang Soo Lee, Young-Sang Byoun, Sook-Hyang Jeong, Yeo Myung Kim, Ho Gil, Bo-Young Min, Mun Hyuk Seong, Eun Sun Jang, Jin-Wook Kim

Clin Mol Hepatol. 2012;18(3):309-315. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.309

View: 9252 Download: 99 Crossref: 50

Viewed By 5504	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5404	MAFLD: How is it different from NAFLD?
Viewed By 5214	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5094	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4725	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Epidemiology, Methodology, or others